Skip to main navigation Skip to search Skip to main content

A Double Blind, Randomised, Placebo controlled Phase 2b/3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients with Vasopressor-dependent Septic Shock

Grants and Contracts Details

StatusFinished
Effective start/end date4/7/17 → 5/31/19

Funding

  • PPD Investigator Services LLC: $48,710.00